AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33667741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) at 40 mm Hg for 45 minutes directly after surgery
Number of subjects: 186
Study 33667741 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IPC)
Number of subjects: 186
Study 33667741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 186
Study 34363104 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Extended Coronally Advanced Flap (MECAF)
Number of subjects: 20
Study 34363104 — intervention group
Group type: COMPARATOR
Intervention: Supra‐periosteal flap (TUN)
Number of subjects: 20
Study 34363104 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain evaluation using Visual Analog Scale (VAS)
Number of subjects: 20
Study 32868152 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II plus standard‐of‐care vasopressors (n=9)
Number of subjects: 16
Study 32868152 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard‐of‐care vasopressors (n=7)
Number of subjects: 16
Study 33350170 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate
Number of subjects: 0
Study 33350170 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 0
Study 33350170 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (placebo treatment period)
Number of subjects: 0
Study 33350170 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent cohort
Number of subjects: 0
Study 35502452 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching program (physical activity, home visits, weekly phone calls)
Number of subjects: 84
Study 35502452 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 84
Study 33844262 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS stimulation
Number of subjects: 115
Study 33844262 — intervention group
Group type: EXPERIMENTAL
Intervention: Water immersion
Number of subjects: 115
Study 33844262 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 115
Study 34182603 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen up to 60 l.min-1 at 100% FIO2
Number of subjects: 132
Study 34182603 — intervention group
Group type: COMPARATOR
Intervention: Low-flow nasal oxygen at 4 l.min-1 plus oxygen through an oxygenating mouthguard totalling 8 l.min-1
Number of subjects: 132
Study 33321089 — intervention group
Group type: EXPERIMENTAL
Intervention: PREHAB (4 weeks before surgery)
Number of subjects: 95
Study 33321089 — intervention group
Group type: COMPARATOR
Intervention: REHAB (8 weeks after surgery)
Number of subjects: 95
Study 33321089 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PREHAB and REHAB)
Number of subjects: 95
Study 34476774 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing care (CNC)
Number of subjects: 134
Study 34476774 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 134
Study 32654677 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition/stimulation/hygiene education intervention
Number of subjects: 155
Study 32654677 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 155
Study 33858441 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sulfur amino acid (SAA) diet (total diet SAA 15–25 mg/kg body weight/day)
Number of subjects: 60
Study 33858441 — intervention group
Group type: COMPARATOR
Intervention: High sulfur amino acid (SAA) diet (total diet SAA 50–60 mg/kg body weight/day)
Number of subjects: 60
Study 32476640 — intervention group
Group type: EXPERIMENTAL
Intervention: Rango Cards game intervention
Number of subjects: 319
Study 32476640 — intervention group
Group type: COMPARATOR
Intervention: Control group (no game or material provided)
Number of subjects: 319
Study 33439140 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanadak app (cognitive behavioral therapy-based self-help)
Number of subjects: 133
Study 33439140 — intervention group
Group type: COMPARATOR
Intervention: Control group (psychoeducational reading material)
Number of subjects: 133
Study 33022957 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring salt concentration in soups
Number of subjects: 195
Study 33022957 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium seasoning
Number of subjects: 195
Study 33022957 — intervention group
Group type: COMPARATOR
Intervention: Control: no monitoring
Number of subjects: 195
Study 33022957 — intervention group
Group type: COMPARATOR
Intervention: Control: regular seasoning
Number of subjects: 195
Study 35267246 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin (2.5 mg, once daily)
Number of subjects: 83
Study 35267246 — intervention group
Group type: COMPARATOR
Intervention: Voglibose (0.2 mg, three times daily)
Number of subjects: 83
Study 33131028 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISPR/dCas9‐SunTag labeling system with redesigned signal module (two copies of EGFP, NLS removed)
Number of subjects: 0
Study 32142518 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Environment (IVE)
Number of subjects: 0
Study 32142518 — intervention group
Group type: COMPARATOR
Intervention: Information Sheet (Control)
Number of subjects: 0
Study 34014324 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) intervention, including psychosocial support and health coaching, maintained contact for 30 days postdischarge.
Number of subjects: 550
Study 34014324 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) intervention for participants discharged to rehabilitation.
Number of subjects: 550
Study 34014324 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) intervention for participants discharged home.
Number of subjects: 550
Study 34014324 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group) including routine care from primary care clinics and outpatient referrals.
Number of subjects: 550
Study 36277941 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly voice message intervention transmitted through mobile phone from recruitment in the first trimester until two weeks postpartum.
Number of subjects: 458
Study 36277941 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 458
Study 33247703 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-message and infographic
Number of subjects: 396
Study 33247703 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 396
Study 34538690 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT
Number of subjects: 63
Study 34538690 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 63
Study 34224476 — intervention group
Group type: EXPERIMENTAL
Intervention: SS-OCT
Number of subjects: 30
Study 34224476 — intervention group
Group type: COMPARATOR
Intervention: RSC
Number of subjects: 30
Study 34224476 — intervention group
Group type: COMPARATOR
Intervention: DSP
Number of subjects: 30
Study 33300266 — intervention group
Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (PA) for 1 min
Number of subjects: 80
Study 33300266 — intervention group
Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 80
Study 33300266 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) for 3 min
Number of subjects: 80
Study 33300266 — intervention group
Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (PA) for 1 min followed by CPP-ACP for 3 min
Number of subjects: 80
Study 33300266 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups after 6 months
Number of subjects: 80
Study 32588785 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in physical activity (PA) during pregnancy
Number of subjects: 89
Study 34474578 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined deep cervical flexor motor-control training and lumbar motor control exercise
Number of subjects: 113
Study 34474578 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep cervical flexor motor control training alone
Number of subjects: 113
Study 34474578 — intervention group
Group type: COMPARATOR
Intervention: Passive treatment and education
Number of subjects: 113
Study 33305818 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (600,000 IU)
Number of subjects: 145
Study 33305818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 33305818 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 145
Study 32452142 — intervention group
Group type: EXPERIMENTAL
Intervention: Female hormones users
Number of subjects: 3211
Study 35172786 — intervention group
Group type: EXPERIMENTAL
Intervention: Beekeeping training
Number of subjects: 0
Study 35172786 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrepreneurship training
Number of subjects: 0
Study 35172786 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 0
Study 33952558 — intervention group
Group type: EXPERIMENTAL
Intervention: LIVES for Families PFA training programme
Number of subjects: 80
Study 33006952 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical vestibular nerve stimulation (VeNS) administered for 30 minutes, 1 hour prior to sleep onset for 14 days using ML1000 device (Neurovalens, UK)
Number of subjects: 0
Study 34448694 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation (250 mg) in fasting group
Number of subjects: 56
Study 34448694 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation (250 mg) in fasting group
Number of subjects: 56
Study 34448694 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation (250 mg) in postprandial group
Number of subjects: 56
Study 34448694 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation (250 mg) in postprandial group
Number of subjects: 56
Study 32871674 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term goal condition
Number of subjects: 127
Study 32871674 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term goal condition
Number of subjects: 127
Study 32871674 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear proneness
Number of subjects: 127
Study 32746952 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g daily of 99% cocoa chocolate for 6 months
Number of subjects: 132
Study 32746952 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 132
Study 35151410 — intervention group
Group type: EXPERIMENTAL
Intervention: Balovaptan (10 mg daily for 24 weeks)
Number of subjects: 322
Study 35151410 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for 24 weeks)
Number of subjects: 322
Study 35151410 — intervention group
Group type: EXPERIMENTAL
Intervention: Balovaptan
Number of subjects: 322
Study 35151410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study 33910836 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) instillations before TURBT and cystoscopy
Number of subjects: 328
Study 33910836 — intervention group
Group type: COMPARATOR
Intervention: Control group (without 5-ALA instillations)
Number of subjects: 328
Study 32697556 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate self-instilled using an alternative method
Number of subjects: 30
Study 32697556 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol maleate administered by a trained clinician
Number of subjects: 30
Study 35953083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention targets including BMI, exercise capacity (peak V̇O2), and health literacy (HL)
Number of subjects: 499
Study 32950444 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip intervention
Number of subjects: 0
Study 36314321 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 + standard therapy (hydroxyurea and folic acid daily with ibuprofen as needed)
Number of subjects: 165
Study 36314321 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D + standard therapy (hydroxyurea and folic acid daily with ibuprofen as needed)
Number of subjects: 165
Study 36314321 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 165
Study 36314321 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 165
Study 36314321 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 165
Study 34400963 — intervention group
Group type: EXPERIMENTAL
Intervention: Semelil (test)
Number of subjects: 44
Study 34400963 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 44
Study 34632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy (50 Gy in 25 fractions)
Number of subjects: 43
Study 34632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy (40 Gy in 15 fractions)
Number of subjects: 43
Study 34632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy with anatomical evaluation
Number of subjects: 43
Study 34632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan adaptation
Number of subjects: 43
Study 34632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Robust optimization
Number of subjects: 43
Study 32456617 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-3-n-butylphthalide (NBP) 200 mg three times daily for four weeks
Number of subjects: 120
Study 32456617 — intervention group
Group type: COMPARATOR
Intervention: Placebo 20 mg three times daily for four weeks
Number of subjects: 120
Study 35166585 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day training plus feedback
Number of subjects: 139
Study 35166585 — intervention group
Group type: COMPARATOR
Intervention: No training or feedback
Number of subjects: 139
Study 32811342 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine (RAI) treatment, fixed dose of 15 mCi
Number of subjects: 83
Study 32811342 — intervention group
Group type: COMPARATOR
Intervention: Long-term Methimazole (MMI) treatment, starting dose of 10 mg daily, decreased to 4.9±1.0, 4.3±1.0, 4.4±1.4, 4.3±1.8, and 3.7±1.3 mg after 1, 2, 3, 4, and 5 years respectively
Number of subjects: 83
Study 35924814 — intervention group
Group type: EXPERIMENTAL
Intervention: More-intensive BP management (target SBP ≤ 120 mmHg within 1 hour)
Number of subjects: 2257
Study 35924814 — intervention group
Group type: COMPARATOR
Intervention: Less-intensive BP management (target SBP 140-180 mmHg)
Number of subjects: 2257
Study 32051177 — intervention group
Group type: EXPERIMENTAL
Intervention: AI2 personal nudging system (text messages for missed medications or health checks)
Number of subjects: 0
Study 32051177 — intervention group
Group type: EXPERIMENTAL
Intervention: AI2 clinical decision support tool (alerts presented to community mental health professionals)
Number of subjects: 0
Study 32051177 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation protocols for AI2
Number of subjects: 0
Study 36462115 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 36462115 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 0
Study 33960149 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of empagliflozin for 12 weeks
Number of subjects: 86
Study 33960149 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 86
Study 36137900 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health messages
Number of subjects: 2701
Study 36137900 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 financial incentive
Number of subjects: 2701
Study 36137900 — intervention group
Group type: EXPERIMENTAL
Intervention: $50 financial incentive
Number of subjects: 2701
Study 36137900 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple vaccination appointment scheduler
Number of subjects: 2701
Study 36137900 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2701
Study 33508723 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented parallel‐sided femoral component implantation
Number of subjects: 65
Study 33508723 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative walking activity (measured three months after surgery)
Number of subjects: 65
Study 33256614 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume leg resistance training (RT)
Number of subjects: 25
Study 33256614 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-volume leg resistance training (RT)
Number of subjects: 25
Study 33256614 — intervention group
Group type: COMPARATOR
Intervention: Traditional normalization and non-normalized models
Number of subjects: 25
Study 33256614 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall training effect
Number of subjects: 25
Study 35564491 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-MetS
Number of subjects: 167
Study 35564491 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-MetS (low sleep satisfaction)
Number of subjects: 167
Study 35564491 — intervention group
Group type: EXPERIMENTAL
Intervention: MetS (low sleep satisfaction)
Number of subjects: 167
Study 35564491 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI (low sleep satisfaction)
Number of subjects: 167
Study 35564491 — intervention group
Group type: COMPARATOR
Intervention: High sleep satisfaction
Number of subjects: 167
Study 33067067 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model including predictors: male gender, respiratory rate≦10 cycles/min, heart rate <60 or ≧120 beats/min, systolic blood pressure <100 mmHg, level of consciousness, oxygen saturation <94%.
Number of subjects: 252771
Study 34617960 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 2.5%
Number of subjects: 20
Study 34617960 — intervention group
Group type: COMPARATOR
Intervention: Control (fellow eye)
Number of subjects: 20
Study 33387427 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (NCRT) with polychemotherapy (cisplatin and paclitaxel) followed by radiotherapy in 25 patients.
Number of subjects: 75
Study 33387427 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (NCRT) with chemoradiomodification (paclitaxel and carboplatin) in 30 patients.
Number of subjects: 75
Study 33387427 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy only in 20 patients (comparison group).
Number of subjects: 75
Study 36098967 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person training intervention
Number of subjects: 2892
Study 36098967 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-tech intervention with in-person training
Number of subjects: 2892
Study 36098967 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-tech intervention
Number of subjects: 2892
Study 34600559 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced expiratory technique and sputum induction
Number of subjects: 280
Study 34600559 — intervention group
Group type: COMPARATOR
Intervention: Tracheal suction
Number of subjects: 280
Study 32576351 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation based on APACHE II score (ventilation initiated when score > 10, weaned when score ≤ 10)
Number of subjects: 106
Study 32576351 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing in ICU with standard mechanical ventilation timing
Number of subjects: 106
Study 35380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib responders
Number of subjects: 261
Study 35380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib nonresponders
Number of subjects: 261
Study 35380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib with low tumor burden (≤40 mm)
Number of subjects: 261
Study 35380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib with high tumor burden (>40 mm)
Number of subjects: 261
Study 35380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline tumor burden
Number of subjects: 261
Study 32998921 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance and standard rehabilitation
Number of subjects: 48
Study 32998921 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 48
Study 33361164 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) point of care testing with additional healthcare worker guidance
Number of subjects: 24960
Study 33361164 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 24960
Study 35398912 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (EG) for 13 weeks
Number of subjects: 50
Study 35398912 — intervention group
Group type: COMPARATOR
Intervention: Normal lifestyle (CG)
Number of subjects: 50
Study 34842993 — intervention group
Group type: EXPERIMENTAL
Intervention: CGFs combined with deproteinized bovine bone mineral (DBBM) and covered with CGFs membrane (CGFs/DBBM group)
Number of subjects: 36
Study 34842993 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM alone and covered with collagen membrane (DBBM group)
Number of subjects: 36
Study 34842993 — intervention group
Group type: COMPARATOR
Intervention: Control group spontaneous healing
Number of subjects: 36
Study 34399434 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-trimester serum proteomics screening and risk-reduction protocol
Number of subjects: 1191
Study 34399434 — intervention group
Group type: COMPARATOR
Intervention: Standard care (unscreened women)
Number of subjects: 1191
Study 34399434 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-trimester serum proteomics screening
Number of subjects: 1191
Study 32851902 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial and vaginal epithelial plication (FEP)
Number of subjects: 22
Study 32851902 — intervention group
Group type: COMPARATOR
Intervention: Standard posterior colporrhaphy (SPC)
Number of subjects: 22
Study 32948554 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mL of intravenous crystalloid
Number of subjects: 1065
Study 32948554 — intervention group
Group type: COMPARATOR
Intervention: No intravenous fluid bolus
Number of subjects: 1065
Study 35276967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran supplementation (1–5 g/day for 6 months)
Number of subjects: 50
Study 35276967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran supplementation
Number of subjects: 50
Study 35276967 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 50